Acid and Barriers: Current Research and Future Developments for Peptic Ulcer Therapy

References

• Schwarz K, Beitz Z. Ueber penetrierende magen-und jejunalgeschwure. Klin Chir 1910; 67: 96–128
   Google Scholar
• Freston JW. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selections. Am J Gastrenterol 1987; 82: 1242–1249
   PubMed Web of Science ®Google Scholar
• Wolfe M M, Soil AM. The physiology of gastric acid secretion. NEJM 1988; 319: 1707–1715
   PubMed Web of Science ®Google Scholar
• Sachs G, Tache Y, Debas H T, et al. Control of gastric secretion. Am J Med 1987; 83: 307–327
   PubMed Web of Science ®Google Scholar
• Fellenius E, Berglindh T, Sachs G, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase. Nature 1981; 159–161
   PubMed Web of Science ®Google Scholar
• Bardhan KD. Omeprazole in the management of refractory duodenal ulcer. Scand J Gastroenterol 1989; 24: 63–73, suppl 166
   Web of Science ®Google Scholar
• Dent J, Hetzel D J, Mac Kinnon M A, et al. Evaluation of omeprazole in reflux oesophagitis. Scand J Gastroenterol 1989; 24: 76–82, suppl 166
   Web of Science ®Google Scholar
• Hakanson R, Sunder F. Gastric carcinoids and antisecretory drugs. TIPS 1986; 7: 386–387
   Web of Science ®Google Scholar
• Lawsson H, Carlsson E, Mattsson H, et al. Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Gastroenterology 1986; 96: 391–399
   Google Scholar
• Solcia E, Rind G, Maru N, Elm G. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol 1989; 24: 129–137, suppl 166
   Web of Science ®Google Scholar
• Szabo S. Mechanisms of mucosal injury in the stomach and duodenum: Time-sequence analysis of morphologic, functional, biochemical and histo-chemical studies. Scand J Gastroenterol 1986; 22: 21–28, suppl 127
   Web of Science ®Google Scholar
• Hawkey C J, Walt RP. Prostaglandins for peptic ulcer: A promise unfulfilled. Lancet 1986; 2: 1084–1086
   PubMed Web of Science ®Google Scholar
• Graham D Y, Agrawal N, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, doubleblind, placebo-controlled trial. Lancet 1988; 2: 1277–1280
   PubMed Web of Science ®Google Scholar
• Miller JP. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient. Scand J Gastroenterol 1989; 2: 16–20, suppl 157
   Google Scholar
• Wagstaff A J, Benfield P, Monk JP. Colloidal bismuth subsitrate. A review of its pharmacodynamics and pharmacokinetic properties, and its therapeutic used in peptic ulcer disease. Drugs 1988; 36: 132–157
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, et al. Prospective doubleblind trial of duodenal relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1442
   PubMed Web of Science ®Google Scholar
• Lambert J R, Hansky J, Davidson A, et al. Campylobacter like organisms (CLO)–in vivo and in vitro susceptibility to antimicrobial and antiulcer therapy. Gastroenterology 1985; 95: 1462
   Google Scholar
• Hagland U, Elander B, Fellenius E, et al. The effects of secretagogues on isolated human gastric glands. Scand J Gastroenterol 1982; 17: 455–460
   PubMed Web of Science ®Google Scholar
• Negutescu P A, Machen TE. Intracellular Ca regulations during secretagogue stimulation of the parietal cell. Am J Physiol 1988; 254: C130–C140
   Google Scholar
• Chiba T, Fisher SK, Park J, et al. Carbamoylcholine and gastrin induced inositol lipid turnover in canine gastric parietal cells. Am J Physiol 1988; 255: G99–G105
   Google Scholar
• Verne T B, Verlarde R T, Cunningham R H, Host-Man SR. Effects of staurosporine on protein kinase C and amylase secretion from pancreatic acini. Am J Physiol 1989; 257: G548–G553
   Google Scholar
• Lindberg P, Brandstrom A, Wallmark B. Structure-activity relationships of omeprazole analogues and their mechanism of action. TiPS 1987; 8: 399–402
   Web of Science ®Google Scholar
• Van der Werf J F, Tipperman H. The histamine H, receptor: A general presynaptic histaminergic regulatory system?. TiPS 1989; 10: 159–162
   PubMed Web of Science ®Google Scholar
• Hervatin F, Dubrasquet M, Lewin M JM. Histamine H, receptors in the regulation of gastrin stimulated gastric acid secretion in conscious cat. Gastroenterology 1989; 96: A207
   Google Scholar
• Buckley N J, Bonner T, Buckley C M, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CKO-KI cells. Mol Pharmacol 1989; 35: 469–76
   PubMed Web of Science ®Google Scholar
• Pfeiffer A, Rochlitz H, Noelke B, et al. Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M, type. Gastroenterology 1990; 98: 218–222
   PubMed Web of Science ®Google Scholar
• Huang S C, Zhang L, Chiang H CV, et al. Benzodiazepine analogues L365.260 and L364J18 as gastrin and pancreatic CCK receptor antagonists. Am J Physiol 1989; 257: G169–G174
   Google Scholar
• Chen M CY, Amirian D A, Toomey M, et al. Pro-stamoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase. Gastroenterology 1988; 94: 1121–1129
   PubMed Web of Science ®Google Scholar
• Park J, Chiba T, Yokolni K, et al. Somatostatin receptors on canine fundus D cells: Evidence for autocrine regulation of gastric somatostatin. Am J Physiol 1989; 257: G235–G241
   Google Scholar
• Schubert M L, Hightower J. Inhibition of acid secretion by conversion is partly mediated by release of fundic somatostatin. Gastroenterology 1989; 97: 561–567
   PubMed Web of Science ®Google Scholar
• Tulassay Z, Gupta R, Pappa J, Bodna A. Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: A prospective, randomized, controlled trial. Am J Gastroenterol 1989; 84: 6–9
   PubMed Web of Science ®Google Scholar
• Samloff IM. Peptic ulcer: The many proteinasse of aggression. Gastroenterology 1989; 96: 586–595
   PubMed Web of Science ®Google Scholar
• Defize J, Hunt RH. Control of pepsinogen synthesis and secretion in chief cell monolayers. Dig Dis Sci 1988; 33: 1588–1589
   Web of Science ®Google Scholar
• Muller M J, Hunt RH. Functional evidence for M| and M3 receptors on canine and guinea pig gastric chief cells respectively. Gastroenterology 1989; 96: A353
   Google Scholar
• Wallace JL. Gastric resistance to acid: is the 'mucus bicarbonate barrier' functionally redundant?. Am J Physiol 1989; 256: G31–G38
   Google Scholar
• Spychal R T, Marrero J M, Saverymuttu S H, et al. Measurement of the surface hydrophobicity of human gastrointestinal tract. Gastroenterology 1989; 97: 104–111
   PubMed Web of Science ®Google Scholar
• Lacey ER. Epithelial restitution in the gastrointestinal tract. J Clin Gastroenterol 1988; 10: S72–S77, suppl 1
   Web of Science ®Google Scholar
• Gannon B, Browning B, Browning J, et al. Mucosal microvascular architecture of the fundus and body of the human stomach. Gastroenterology 1984; 86: 866–875
   PubMed Web of Science ®Google Scholar
• Hui W M, Liu H C, Lam SK. Enterochromaffin-like cells of the human stomach–demonstration of histamine content and cholinergic nerve supply. Cell Mol Biol 1988; 34: 303–9
   PubMed Web of Science ®Google Scholar
• Beck P I, Morris GP. Ethanol-induced vascular permeability changes in the jejunal mucosa of the dog. Gastroenterology 1986; 90: 1162
   Web of Science ®Google Scholar
• Holzer P, Sametz W. Gastric mucosal protection against ulcerogenic factor in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 1986; 91: 975–981
   PubMed Web of Science ®Google Scholar
• Holzer P, Pasbst M A, Lippe IT. Intragastric capsaicin protects against aspirin-induced lesion formations and bleeding in the rat gastric mucosa. Gastroenterology 1989; 96: 1425–1433
   PubMed Web of Science ®Google Scholar
• Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24: 739–768
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986; 31: 1114–1122
   PubMed Web of Science ®Google Scholar
• Kerrigan D D, Read N W, Taylor M E, et al. Duodenal bulb acidity and the natural history of duodenal ulceration. Lancet 1989; 2: 61–63
   PubMed Web of Science ®Google Scholar
• Stead R H, Dixon M F, Brummell N H, et al. Mast cells are closely opposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989; 97: 575–585
   PubMed Web of Science ®Google Scholar
• Itoh M, Guth PH. Rate of oxygen-derived free radicals in hemorrhagic-shock induced gastric lesions in the rat. Gastroenterology 1985; 88: 1162–1167
   PubMed Web of Science ®Google Scholar
• Ogino K, Oka S, Okanzaki Y, Takemoto T. Gastric mucosal protection and superoxide dismutase. J Clin Gastroenterol 1988; 10: S129–S132, suppl 1
   Web of Science ®Google Scholar
• Konturek J W, Bielanski W, Konturek S J, et al. Distribution and release of epidermal growth factor in man. Gut 1989; 30: 1199–1200
   Web of Science ®Google Scholar
• Itoh M, Joh T, Imai S, et al. Experimental and clinical studies on epidermal growth factor for gastric mucosal protection and healing of gastric ulcers. J Clin Gastroenterol 1988; 10: S7–S12, suppl 1
   Web of Science ®Google Scholar
• Konturek S J, Bielanski W, Konturek J W, et al. Release and action of epidermal growth factor on gastric secretion in humans. Scand J Gastroenterol 1989; 24: 485–492
   PubMed Web of Science ®Google Scholar
• Yakabi K, Masoaka I, Kakamura T. The mechanism for direct inhibition of canine gastric parietal cells by epidermal growth factor. Gastroenterology 1990; 98: A150
   Google Scholar
• Olimura E, Emoto N M, Tsushima T, et al. Salivary immunoreactive human epidermal growth factors (IR-hEGF) in patients with peptic ulcer disease. Hepato. Gastroenterology 1987; 34: 160–163
   Web of Science ®Google Scholar
• Gilchrist W, Maydonovitch C L, Andrada F, et al. Indomethacin inhibits salivary epidermal growth factor in humans. Gastroenterology 1989; 96: A171
   Google Scholar
• Wright N A, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990; 343: 82–85
   PubMed Web of Science ®Google Scholar
• Szabo S, Vatty P, Morales R E, et al. Oral administration of bFGF mutein: effect on healing of chronic duodenal ulcers in rats. Dig Dis Sci 1989; 34: 1323
   Google Scholar
• Moshal M B, Gregory M A, Pillay C, Spitaels J M. Does the duodenal cell every return to normal? A comparison between treatment with cimetidine and Denol. Scand J Gastroenterol 1979; 14: 48–51
   Web of Science ®Google Scholar
• Jones D B, Howden C W, Burget D W, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120–1127
   PubMed Web of Science ®Google Scholar
• Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345–351
   PubMed Web of Science ®Google Scholar
• Poynter D, Pick C R, Harcourt R A, et al. Association of longlasting unsurmountable histamine H2 blockade and gastric carcinoid tumors in the rat. Gut 1985; 26: 1284–1295
   PubMed Web of Science ®Google Scholar
• Simon B, Muller P, Bliesath H, et al. Gastrin as an autocrine growth factor for islet tumor cells. Gastroenterology 1989; 96: A473
   Google Scholar
• Yamamoto O, Tanaka H, Ueda F, Kimura K. Inhibition of H+ K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl) - benzimidazole - 4 - carboxyl-ate (ALE-36). Scand J Gastroenterol 1989; 24: 178–181, suppl 162
   Web of Science ®Google Scholar
• Wilder-Smith C H, Ernst T, Gennomi M, et al. Acute tolerance in H2-receptor agonists. Aliment Pharmacol Ther 1989; 3, suppl 1, in press
   Google Scholar
• Watson S A, Durrant L G, Morris DL. Effect of L-365,260, a potent gastrin receptor antagonist on the in vitro growth of animal and human gastrointestinal tumor cells. Gut 1989; 30: A1447
   Web of Science ®Google Scholar
• Coelho L GV, Queiroz D MM, Barbosa A JA, et al. Furazolidone vs cimetidine in duodenal ulcer C. pylori positive patients. Gastroenterology 1989; 96: A91
   Google Scholar
• Hernandez DE. Neurobiology of brain-gut interactions: Implications for ulcer disease. Dig Dis Sci 1989; 34: 1809–1816
   PubMed Web of Science ®Google Scholar
• Cohen JS. Designing antisense oligonucleotides as pharmaceutical agents. TiPS 1989; 10: 435–437
   PubMed Web of Science ®Google Scholar